Therefore, blockade of mTOR signaling by Everolimus was used to examine whether maturation, apoptosis and the release of IL-1β by A20-dependent macrophages in cHL patients are associated with this signaling. The gene discussed is TNFAIP3; the disease is classic Hodgkin lymphoma.